FDA Adverse Event
Injury
Summary report: N
ENDOBON XENOGRAFT GRANULES .5ML,500-1000
MDR report key: 6029856
·
Received October 14, 2016
Report
- Report Number
- 3006946279-2016-00376
- Event Type
- Injury
- Date Received
- October 14, 2016
- Report Date
- September 16, 2016
- Manufacturer
- BIOMET FRANCE S.A.R.L.
- Product Code
- LYC
- PMA / PMN Number
- PN/A
- Removal / Correction Number
- FR 2015-03
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- DENTIST
Narratives
Additional Manufacturer Narrative · 1
THIS USER FACILITY IS OUTSIDE THE UNITED STATES. CURRENT INFORMATION IS INSUFFICIENT TO PERMIT A CONCLUSION AS TO THE CAUSE OF THE EVENT. REVIEW OF DEVICE HISTORY RECORDS REVEALS NO RECORDED ANOMALY OR DEVIATION. EVENT DATE - NI, EXPLANT DATE - NI, THIS PRODUCT IS MANUFACTURED BY ZIMMER BIOMET (B)(4) AND IS NOT CLEARED FOR DISTRIBUTION IN THE U.S.; HOWEVER, THIS REPORT IS BEING FILED AND ZIMMER BIOMET IN THE U.S. MANUFACTURES A SIMILAR DEVICE UNDER 510K NUMBER K110449. CORRECTIVE ACTION WAS INITIATED FOR THE REPORTED ISSUE.
Description of Event or Problem · 1
IT WAS REPORTED THAT THE ORAL BONE GRAFTING MATERIAL FAILED TO OSSEOINTEGRATE AND WAS REMOVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 680616 | ENDOBON XENOGRAFT GRANULES .5ML,500-1000 | BONE GRAFTING MATERIAL, SYNTHETIC | LYC | BIOMET FRANCE S.A.R.L. | N/A | U0132316 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |